A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy

Cell Research
Xuexiang DuYang Liu

Abstract

It is assumed that anti-CTLA-4 antibodies cause tumor rejection by blocking negative signaling from B7-CTLA-4 interactions. Surprisingly, at concentrations considerably higher than plasma levels achieved by clinically effective dosing, the anti-CTLA-4 antibody Ipilimumab blocks neither B7 trans-endocytosis by CTLA-4 nor CTLA-4 binding to immobilized or cell-associated B7. Consequently, Ipilimumab does not increase B7 on dendritic cells (DCs) from either CTLA4 gene humanized (Ctla4 h/h ) or human CD34+ stem cell-reconstituted NSG™ mice. In Ctla4 h/m mice expressing both human and mouse CTLA4 genes, anti-CTLA-4 antibodies that bind to human but not mouse CTLA-4 efficiently induce Treg depletion and Fc receptor-dependent tumor rejection. The blocking antibody L3D10 is comparable to the non-blocking Ipilimumab in causing tumor rejection. Remarkably, L3D10 progenies that lose blocking activity during humanization remain fully competent in inducing Treg depletion and tumor rejection. Anti-B7 antibodies that effectively block CD4 T cell activation and de novo CD8 T cell priming in lymphoid organs do not negatively affect the immunotherapeutic effect of Ipilimumab. Thus, clinically effective anti-CTLA-4 mAb causes tumor rejection by me...Continue Reading

References

Nov 11, 1992·European Journal of Immunology·Y LiuP S Linley
Sep 1, 1991·The Journal of Experimental Medicine·P S LinsleyJ A Ledbetter
Aug 1, 1995·The Journal of Experimental Medicine·M F Krummel, J P Allison
Aug 1, 1994·Immunity·T L WalunasJ A Bluestone
Mar 22, 1996·Science·D R LeachJ P Allison
Apr 7, 1997·The Journal of Experimental Medicine·Y WuY Liu
Jan 13, 1998·Immunology Today·Y Liu
Dec 18, 1998·Science·K M LeeJ A Bluestone
Jun 27, 2003·Proceedings of the National Academy of Sciences of the United States of America·Giao Q PhanSteven A Rosenberg
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tibor KelerAlan Korman
May 30, 2006·Advances in Immunology·Alan J KormanJames P Allison
Oct 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Thanh V NguyenGen-Sheng Feng
Oct 11, 2008·Science·Kajsa WingShimon Sakaguchi
Dec 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Anna I ProiettoLi Wu
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Nov 26, 2011·Nature Reviews. Immunology·Lucy S K Walker, David M Sansom
Jul 31, 2013·The Journal of Experimental Medicine·Yannick BulliardJennifer L Brogdon
Jan 30, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tie Zheng HouDavid M Sansom
Sep 2, 2015·The Journal of Clinical Investigation·Lieping Chen, Xue Han
Apr 14, 2016·Proceedings of the National Academy of Sciences of the United States of America·Katrin KlockeKajsa Wing
May 10, 2017·Proceedings of the National Academy of Sciences of the United States of America·Udupi A RamagopalSteven C Almo
Jun 28, 2017·Immunotherapy·Andrew W HahnNeeraj Agarwal

❮ Previous
Next ❯

Citations

Mar 30, 2018·Cell Research·Jonathan Pol, Guido Kroemer
Nov 13, 2018·Journal of Cellular Physiology·Masoud NajafiKeywan Mortezaee
Dec 7, 2018·Journal of Cellular Physiology·Bagher FarhoodKeywan Mortezaee
Nov 30, 2018·International Journal of Molecular Sciences·Mathieu CésaireFrançois Chevalier
Mar 1, 2019·Clinical Pharmacokinetics·Maddalena CentanniJ G Coen van Hasselt
Jan 10, 2019·ESMO Open·Yochai Wolf, Yardena Samuels
Feb 23, 2020·Expert Opinion on Therapeutic Targets·Keisaku SatoGianfranco Alpini
May 21, 2020·Nature Reviews. Immunology·Alex D WaldmanMichael J Lenardo
May 30, 2020·Cell Research·Yonina R Murciano-GoroffJedd D Wolchok
Sep 15, 2020·Science China. Life Sciences·Zhangsong WuSong Wu
May 7, 2019·Frontiers in Oncology·SeongJun HanPamela S Ohashi
Jul 14, 2019·Cell Research·Amnon Altman, Kok-Fai Kong
Nov 5, 2019·Frontiers in Immunology·Christina M PaluskieviczJonathan S Bromberg
Feb 6, 2020·Médecine sciences : M/S·Kevin Thierry, Christine Ménétrier-Caux
Dec 12, 2018·Journal of Cellular Physiology·Amirhossein AhmadiKeywan Mortezaee
Jun 14, 2019·Frontiers in Immunology·Thaiz Rivera Vargas, Lionel Apetoh
Oct 23, 2019·Signal Transduction and Targeted Therapy·Ziying ZhangYongguang Tao
Oct 17, 2019·Journal of Clinical Medicine·Emilio Sanseviero
Mar 10, 2020·The Journal of Clinical Investigation·Simone A Minnie, Geoffrey R Hill
Aug 12, 2020·Therapeutic Delivery·Swatantra ShrivastavaAkshay Ragit
Sep 12, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Soehartati A GondhowiardjoAngela Giselvania
Jan 10, 2019·Nature Reviews. Drug Discovery·Rachel S RileyMichael J Mitchell
Nov 7, 2019·Cell Research·UNKNOWN Cell Research Editorial Team
May 7, 2020·Journal of Hematology & Oncology·Jifeng YuWenzhi Tian
Oct 24, 2018·Frontiers in Immunology·Christopher PaluchSimon J Davis
Feb 11, 2020·Journal of Drug Targeting·Tongtong QiGuimei Lin
Apr 13, 2019·Journal for Immunotherapy of Cancer·Anne Månsson KvarnhammarPeter Ellmark
Sep 6, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Fang YangJianhua Sui
Nov 5, 2020·Immunology and Cell Biology·Andrew A AlmonteAude M Fahrer
Aug 18, 2018·Cancer Discovery·Spencer C WeiJames P Allison
Jun 27, 2019·Cancer Immunology Research·Emilio SansevieroErica L Stone
Jul 29, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anu SharmaPadmanee Sharma

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
FACS
gene knock-in
targeted mutations
biosensors
ELISA

Software Mentioned

Excel
R
GraphPad Prism

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Deirdre O'MahonyJohn E Janik
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Penghui ZhouPan Zheng
The Journal of Immunology : Official Journal of the American Association of Immunologists
John J EngelhardtJames P Allison
© 2022 Meta ULC. All rights reserved